3D MRI of impaired hyperpolarized 129Xe uptake in a rat model of pulmonary fibrosis

NMR in Biomedicine

Volumn 27, Issue 12, 2014, Pages 1502-1514

  Cleveland, Zackary I ^a,d   Virgincar, Rohan S ^a,b   Qi, Yi ^a   Robertson, Scott H ^a   Degan, Simone ^a,c   Driehuys, Bastiaan ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b USA   (United States)

^c DUKE UNIVERSITY   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Chemical shift; Diffusion impairment; Dixon imaging; Gas exchange; ILD; Interstitial lung disease; IPF; Xenon 129

Indexed keywords

ANIMALS; BIOLOGICAL ORGANS; CHEMICAL SHIFT; DISSOLUTION; GASES; HISTOLOGY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; TISSUE;

CONTROL GROUPS; EXPERIMENTAL GROUPS; GAS EXCHANGE; INTERSTITIAL LUNG DISEASE; MR SPECTROSCOPY; PULMONARY FIBROSIS; PULMONARY TISSUES; RED BLOOD CELL;

BLOOD;

RADIOISOTOPE; UNCLASSIFIED DRUG; XENON 129; BLEOMYCIN; SODIUM CHLORIDE; XENON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GAS EXCHANGE; HYPERPOLARIZATION; IMAGE ANALYSIS; LUNG FIBROSIS; LUNG HEMODYNAMICS; LUNG INTERSTITIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMA; PRESSURE GRADIENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAT; THERMODYNAMICS; THREE DIMENSIONAL IMAGING; ANIMAL; DISEASE MODEL; FISCHER 344 RAT; LUNG; METABOLISM; PATHOLOGY; PULMONARY FIBROSIS; REPRODUCIBILITY; SIGNAL PROCESSING; SPECTROSCOPY;

RATTUS;

ANIMALS; BLEOMYCIN; DISEASE MODELS, ANIMAL; ERYTHROCYTES; FEMALE; IMAGING, THREE-DIMENSIONAL; LUNG; MAGNETIC RESONANCE IMAGING; PULMONARY FIBROSIS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SODIUM CHLORIDE; SPECTRUM ANALYSIS; XENON ISOTOPES;

EID: 84908449382     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.3127     Document Type: Article

References (55)

1. West JB. Respiratory Physiology: the Essentials, 9th edn. Lippincott Williams and Wilkins: Baltimore, MD, 2012.
2. Robertson HT, Buxton RB. Imaging for lung physiology: what do we wish we could measure? J. Appl. Physiol. 2012; 113(2): 317-327.
3. Fain S, Schiebler ML, McCormack DG, Parraga G. Imaging of lung function using hyperpolarized helium-3 magnetic resonance imaging: review of current and emerging translational methods and applications. J. Magn. Reson. Imaging 2010; 32(6): 1398-1408.
4. Hopkins SR, Prisk GK. Lung perfusion measured using magnetic resonance imaging: new tools for physiological insights into the pulmonary circulation. J. Magn. Reson. Imaging 2010; 32(6): 1287-1301.
5. Hegewald MJ. Diffusing capacity. Clin. Rev. Allergy Immunol. 2009; 37(3): 159-166.
6. Fishbein MC. Assessing the role of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis. Chest 2005; 128(5): 520S-525S.
7. 129Xe magnetic resonance imaging: tolerability in healthy volunteers and subjects with pulmonary disease. Acad. Radiol. 2012; 19(8): 941-951.
8. 129Xe MR imaging in healthy volunteers and patients. Radiology 2012; 262(1): 279-289.
9. 129Xe in patients with chronic obstructive pulmonary disease. Magn. Reson. Med. 2011; 65(4): 1154-1165.
10. Mata JF, Altes TA, Cai J, Ruppert K, Mitzner W, Hagspiel KD, Patel B, Salerno M, Brookeman JR, de Lange EE, Tobias WA, Wang HTJ, Cates GD, Mugler JP. Evaluation of emphysema severity and progression in a rabbit model: comparison of hyperpolarized He-3 and Xe-129 diffusion MRI with lung morphometry. J. Appl. Physiol. 2007; 102(3): 1273-1280.
11. 129Xe gas apparent diffusion coefficient anisotropy in an elastase-instilled rat model of emphysema. Magn. Reson. Med. 2013; 69(1): 211-220.
12. 129Xe ventilation imaging in healthy volunteers and subjects with chronic obstructive pulmonary disease. NMR Biomed. 2013; 26(4): 424-435.
13. Kirby M, Svenningsen S, Kanhere N, Owrangi A, Wheatley A, Coxson HO, Santyr GE, Paterson NAM, McCormack DG, Parraga G. Pulmonary ventilation visualized using hyperpolarized helium-3 and xenon-129 magnetic resonance imaging: differences in COPD and relationship to emphysema. J. Appl. Physiol. 2013; 114(6): 707-715.
14. 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265(2): 600-610.
15. Mugler JP, Driehuys B, Brookeman JR, Cates GD, Berr SS, Bryant RG, Daniel TM, deLange EE, Downs JH, Erickson CJ, Happer W, Hinton DP, Kassel NF, Maier T, Phillips CD, Saam BT, Sauer KL, Wagshul ME. MR imaging and spectroscopy using hyperpolarized Xe-129 gas: preliminary human results. Magn. Reson. Med. 1997; 37(6): 809-815.
16. 129Xe magnetization In vivo. Magn. Reson. Med. 1999; 42(6): 1137-1145.
17. 129Xe rat head spectra. Magn. Reson. Med. 2007; 57(4): 791-797.
18. Ruppert K, Brookeman JR, Hagspiel KD, Mugler JP. Probing lung physiology with xenon polarization transfer contrast (XTC). Magn. Reson. Med. 2000; 44(3): 349-357.
19. Dregely I, Ruset IC, Mata JF, Ketel J, Ketel S, Distelbrink J, Altes TA, Mugler JP, Miller GW, Hersman FW, Ruppert K. Multiple-exchange-time xenon polarization transfer contrast (MXTC) MRI: initial results in animals and healthy volunteers. Magn. Reson. Med. 2012; 67(4): 943-953.
20. 129Xe MR imaging. J. Appl. Physiol. 2013; 115(6): 850-860.
21. 129Xe MR imaging of alveolar gas uptake in humans. PLoS One 2010; 5(8): e12192.
22. Mugler JP, Altes TA, Ruset IC, Dregely IM, Mata JF, Miller GW, Ketel S, Ketel J, Hersman FW, Ruppert K. Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc. Natl. Acad. Sci. U. S. A. 2010; 107(50): 21707-21712.
23. 129Xe magnetic resonance of the lung. Magn. Reson. Med. 2013; 69(3): 884-890.
24. 129Xe. Magn. Reson. Med. 2003; 50(6): 1170-1179.
25. 129Xe MRI. Proc. Natl. Acad. Sci. U. S. A. 2006; 103(48): 18278-18283.
26. Ma JF. Dixon techniques for water and fat imaging. J. Magn. Reson. Imaging 2008; 28(3): 543-558.
27. Forster RE. Diffusion of gases across the alveolar membrane. In Comprehensive Physiology. 2011; 71-88.
28. 129Xe septal uptake and experimental results. New J. Phys. 2011; 13: 015009.
29. 129Xe MRI and dynamic spectroscopy in a single breath-hold. Magn. Reson. Med. 2006; 56(2): 255-264.
30. Roughton FJW, Forster RE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J. Appl. Physiol. 1957; 11(2): 290-302.
31. Stitt JT, DuBois AB. The lung diffusing capacity for nitric oxide in rats is increased during endotoxemia. J. Appl. Physiol. 2001; 90(3): 1049-1056.
32. Nouls J, Fanarjian M, Hedlund L, Driehuys B. A Constant-volume ventilator and gas recapture system for hyperpolarized gas MRI of mouse and rat lungs. Concepts Magn. Reson. B 2011; 39(2): 78-88.
33. Lin R, Degan S, Theriot BS, Fischer BM, Strachan RT, Liang JR, Pierce RA, Sunday ME, Noble PW, Kraft M, Brody AR, Walker JKL. Chronic treatment In vivo with beta-adrenoceptor agonists induces dysfunction of airway beta(2)-adrenoceptors and exacerbates lung inflammation in mice. Br. J. Pharmacol. 2012; 165(7): 2365-2377.
34. Fischer BM, Wong JK, Degan S, Kummarapurugu AB, Zheng S, Haridass P, Voynow JA. Increased expression of senescence markers in cystic fibrosis airways. Am. J. Physiol. Lung Cell. Mol. Physiol. 2013; 304(6): L394-L400.
35. 129Xe. Appl. Phys. Lett. 1996; 69(12): 1668-1670.
36. 129Xe. Magn. Reson. Med. 2008; 60(1): 14-20.
37. 129Xe in a deflating polymer bag. J. Magn. Reson. 2011; 212(1): 109-115.
38. 129Xe. PLoS One 2012; 7(2): e12192.
39. 129Xe MR. J. Magn. Reson. B 1996; 113(2): 179-183.
40. Fessler JA. Matlab Tomography Toolbox. http://web.eecs.umich.edu/~fessler/code [11 May 2012].
41. Fessler JA, Sutton BP. Nonuniform fast Fourier transforms using min-max interpolation. IEEE Trans. Signal Process. 2003; 51(2): 560-574.
42. Pipe JG, Menon P. Sampling density compensation in MRI: rationale and an iterative numerical solution. Magn. Reson. Med. 1999; 41(1): 179-186.
43. 2*comparisons at 1.5T and 3T. Magn. Reson. Med. 2012; 68(6): 1900-1904.
44. 2*. Magn. Reson. Med. 1999; 42(4): 729-737.
45. Qing K, Ruppert K, Jiang Y, Mata JF, Miller GW, Shim YM, Wang C, Ruset IC, Hersman FW, Altes TA, Mugler JP. Regional mapping of gas uptake by blood and tissue in the human lung using hyperpolarized xenon-129 MRI. J. Magn. Reson. Imaging 2014; 39(2): 346-359.
46. Bifone A, Song YQ, Seydoux R, Taylor RE, Goodson BM, Pietrass T, Budinger TF, Navon G, Pines A. NMR of laser-polarized xenon in human blood. Proc. Natl. Acad. Sci. U. S. A. 1996; 93(23): 12932-12936.
47. 2 meniscal tissue. Magn. Reson. Med. 2012; 67(4): 991-1003.
48. 129Xe. Magn. Reson. Med. 2014. DOI: 10.1002/mrm.25089.
49. Chen RYZ, Fan FC, Kim S, Jan KM, Usami S, Chien S. Tissue-blood partition-coefficient for xenon - temperature and hematocrit dependence. J. Appl. Physiol. 1980; 49(2): 178-183.
50. Ladefoge J, Andersen AM. Solubility of xenon-133 at 37°C in water, saline, olive oil, liquid paraffin, solutions of albumin, and blood. Phys. Med. Biol. 1967; 12(3): 353-358.
51. Babin AL, Cannet C, Gerard C, Wyss D, Page CP, Beckmann N. Noninvasive assessment of bleomycin-induced lung injury and the effects of short-term glucocorticosteroid treatment in rats using MRI. J. Magn. Reson. Imaging 2011; 33(3): 603-614.
52. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am. J. Respir. Crit. Care Med. 2006; 173(7): 769-776.
53. Fuld MK, Halaweish AF, Haynes SE, Divekar AA, Guo JF, Hoffman EA. Pulmonary perfused blood volume with dual-energy CT as surrogate for pulmonary perfusion assessed with dynamic multidetector CT. Radiology 2013; 267(3): 747-756.
54. 3He magnetic resonance functional imaging semiautomated segmentation. Acad. Radiol. 2012; 19(2): 141-152.
55. 129Xe MR spectroscopy and imaging of pulmonary gas transfer to the red blood cells in transgenic mice expressing human hemoglobin. Magn. Reson. Med. 2013; 70(5): 1192-1199.